Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration Patients: 3-Year Outcomes

被引：0
|
作者：
Wijeyakumar, Wijeyanthy [1 ,2 ]
Zhu, Meidong [1 ,2 ]
Chang, Andrew Alexander [1 ,2 ]
机构：
[1] Sydney Inst Vis Sci, Sydney, NSW, Australia
[2] Univ Sydney, Save Sight Inst, Sydney, NSW, Australia
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4965
引用
收藏
页数：2
相关论文
共 50 条
  • [21] One-Year Outcomes of Faricimab Treatment for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
    Rush, Ryan B.
    [J]. CLINICAL OPHTHALMOLOGY, 2023, 17 : 2201 - 2208
  • [22] AFLIBERCEPT FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Verner-Cole, E. A.
    Davis, S. J.
    Lauer, A. K.
    [J]. DRUGS OF TODAY, 2012, 48 (05) : 317 - 329
  • [23] Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration
    Ohr, Matthew
    Kaiser, Peter K.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (04) : 585 - 591
  • [24] Tolerating subretinal fluid in the treatment of neovascular age-related macular degeneration with intravitreal aflibercept
    Yildiz, Dilan
    Cakir, Akin
    Erden, Burak
    Bolukbasi, Selim
    Erdenoz, Serkan
    Elcioglu, Mustafa Nuri
    [J]. THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2021, 13
  • [25] Characteristics of patients with neovascular age-related macular degeneration who are nonresponders to intravitreal aflibercept
    Hara, Chikako
    Wakabayashi, Taku
    Toyama, Hiroshi
    Fukushima, Yoko
    Sayanagi, Kaori
    Sato, Shigeru
    Sakaguchi, Hirokazu
    Nishida, Kohji
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2019, 103 (05) : 623 - 629
  • [26] Two-year outcomes of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab
    Izawa, Hidetomo
    Azuma, Keiko
    Matsuda, Aya
    Shimizu, Kimiko
    Tan, Xue
    Inoue, Tatsuya
    Obata, Ryo
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [27] Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
    Said, Yasmin Ali
    Vanwynsberghe, David
    Jacob, Julie
    [J]. CASE REPORTS IN OPHTHALMOLOGY, 2022, 13 (01): : 247 - 252
  • [28] Aflibercept for neovascular age-related macular degeneration
    Sarwar, Salman
    Clearfield, Elizabeth
    Soliman, Mohamed Kamel
    Sadiq, Mohammad Ali
    Baldwin, Andrew J.
    Hanout, Mostafa
    Agarwal, Aniruddha
    Sepah, Yasir J.
    Do, Diana V.
    Quan Dong Nguyen
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02):
  • [29] Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration
    Florian M. Heussen
    Qing Shao
    Yanling Ouyang
    Antonia M. Joussen
    Bert Müller
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2014, 252 : 909 - 915
  • [30] Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration
    Heussen, Florian M.
    Shao, Qing
    Ouyang, Yanling
    Joussen, Antonia M.
    Mueller, Bert
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 252 (06) : 909 - 915
12345